A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression. (Q55462761)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression. |
scientific article |
Statements
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression. (English)
1 reference
1 reference
David Mathieu
1 reference
Annick Desjardins
1 reference
Isabelle Vallières
1 reference
Warren P Mason
1 reference
Karl Belanger
1 reference
Garth Nicholas
1 reference
Petr Kavan
1 reference
Didier Reymond
1 reference
3 November 2011
1 reference
107
1 reference
2
1 reference
343-349
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference